Lin Nan, Brooks Jeanne, Sealover Natalie, George Henry J, Kayser Kevin J
Cell Sciences and Development, SAFC/Sigma-Aldrich, 2909 Laclede Ave., St. Louis, MO 63103, USA.
Cell Sciences and Development, SAFC/Sigma-Aldrich, 2909 Laclede Ave., St. Louis, MO 63103, USA.
J Biotechnol. 2015 Jan 10;193:91-9. doi: 10.1016/j.jbiotec.2014.10.040. Epub 2014 Nov 13.
We report the discovery and validation of a novel CHO cell engineering target for improving IgG expression, serpin peptidase inhibitor, clade B, member 1 (Serpinb1). Transcriptomic studies using microarrays revealed that Serpinb1 was up-regulated in cultures with IgG heavy and light chain transcription transiently repressed compared with cultures treated with non-targeting siRNA. As proof of concept, a lentiviral vector was employed to overexpress the Chinese Hamster Serpinb1 in a CHOZN(®) Glutamine Synthetase (-/-) recombinant IgG producing CHO line. The lentiviral stable pool demonstrated 4.2-fold SERPINB1 overexpression compared with the non-transduced control. The peak viable cell density (VCD) and peak IgG volumetric productivity of the lentiviral stable pool increased 1.3 and 2.0 fold, respectively, compared with the non-transduced control. For host cell engineering, a plasmid encoding SERPINB1 was transfected into the CHOZN(®) GS (-/-) host cell line to create several stable pools. Single-cell clones isolated from the pools were characterized for their SERPINB1 expression levels and growth. The clone (SERPINB1_OE_27) with the highest SERPINB1 expression had decreased peak viable cell density and exponential phase growth rate. Selected SERPINB1 OE clones were subsequently evaluated for their IgG expression capabilities using GS selection. Clone SERPINB1_OE_42 with moderate SERPINB1 overexpression demonstrated increased IgG productivity in "bulk" selection. We conclude that manipulating Serpinb1 expression can lead to increased recombinant IgG productivity, but the effect in host cell lines may vary by clone and by overexpression level. This work represents the ongoing effort in applying "-omics" findings to novel CHO host cell line engineering.
我们报告了一种用于提高IgG表达的新型CHO细胞工程靶点——丝氨酸蛋白酶抑制剂B家族成员1(Serpinb1)的发现与验证。使用微阵列进行的转录组学研究表明,与用非靶向siRNA处理的培养物相比,在IgG重链和轻链转录瞬时抑制的培养物中Serpinb1上调。作为概念验证,采用慢病毒载体在CHOZN(®)谷氨酰胺合成酶(-/-)重组IgG生产CHO细胞系中过表达中国仓鼠Serpinb1。与未转导的对照相比,慢病毒稳定细胞库显示SERPINB1过表达4.2倍。与未转导的对照相比,慢病毒稳定细胞库的峰值活细胞密度(VCD)和峰值IgG体积生产力分别提高了1.3倍和2.0倍。对于宿主细胞工程,将编码SERPINB1的质粒转染到CHOZN(®) GS(-/-)宿主细胞系中以创建几个稳定细胞库。从这些细胞库中分离出的单细胞克隆对其SERPINB1表达水平和生长进行了表征。SERPINB1表达最高的克隆(SERPINB1_OE_27)的峰值活细胞密度和指数生长期生长速率降低。随后使用GS选择评估选定的SERPINB1过表达克隆的IgG表达能力。SERPINB1过表达适中的克隆SERPINB1_OE_42在“批量”选择中显示出IgG生产力增加。我们得出结论,操纵Serpinb1表达可导致重组IgG生产力提高,但在宿主细胞系中的效果可能因克隆和过表达水平而异。这项工作代表了将“组学”研究结果应用于新型CHO宿主细胞系工程的持续努力。